Quick Answer
MARAVAI LIFESCIENCES HOLDINGS, INC. reported Research And Development Expense of $17.40 million for the year ending 2025.
- MARAVAI LIFESCIENCES HOLDINGS, INC. showed a decrease of -9.5% in Research And Development Expense from 2024 to 2025.
- This data is from MARAVAI LIFESCIENCES HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $3.74 million | Q2 2020: $1.60 million | Q3 2020: $1.87 million | Q1 2021: $2.16 million | Q2 2021: $1.93 million | Q3 2021: $1.95 million | Q1 2022: $3.70 million | Q2 2022: $4.27 million | Q3 2022: $5.39 million | Q1 2023: $4.15 million | Q2 2023: $4.19 million | Q3 2023: $4.35 million | Q1 2024: $5.03 million | Q2 2024: $4.92 million | Q3 2024: $4.70 million | Q1 2025: $4.89 million | Q2 2025: $4.88 million | Q3 2025: $3.84 million.
- Over the full 7 years of available data (2019 to 2025), MARAVAI LIFESCIENCES HOLDINGS, INC.'s Research And Development Expense has grown by 379.8%.
- Historical annual values: Fiscal year 2025: $17.40 million | Fiscal year 2024: $19.22 million | Fiscal year 2023: $17.28 million | Fiscal year 2022: $18.37 million | Fiscal year 2021: $15.22 million | Fiscal year 2020: $9.30 million | Fiscal year 2019: $3.63 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: